Antibody Testing determines whether antibodies are present in your blood.
The U.S. Food and Drug Administration (FDA) states that "The tests detect the presence of antibodies in the blood – if antibodies are present, that indicates that the person has been exposed to the virus and developed antibodies against it"
This means that your Antibody test results show whether your immune system has produced these antibodies in response to having been exposed to the Coronavirus.
An Antibody testing study with 15,000 participants in New York State found COVID-19 Antibodies in 19,9% of tested individuals in New York City, which means almost 1 out of 5 New York City residents had COVID-19 Antibodies.
Find out today if your body developed COVID-19 Antibodies.
Our laboratory partner will test your blood sample using a SARS-CoV-2 IgG immunoassay test with a Sensitivity of over 90%.
The SARS-CoV-2 IgG assay is a chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgG antibodies to SARS-CoV-2 in serum.
Unlike rapid tests with mostly a low sensitivity and accuracy, an immunoassay test has over 90% Sensitivity and a Specificity of 99-100% according to our laboratory partner, making it one of the most accurate antibody tests on the market.
An infection with COVID-19 is followed by an incubation period of up to 14 days.
The incubation period is followed by the active phase for up to 21 days during which you may or may not show symptoms.
Around 7 days after the end of the incubation phase, most humans typically start slowly building IgG antibodies to fight off the infection.
A positive result for IgG antibodies may suggest an immune response to a primary infection with SARS-CoV-2, but the relationship between IgG positivity and immunity has not yet been firmly established.
It also has yet to be determined how long IgG antibodies are able to be found in your blood and how quickly the Antibody levels decrease over time. It is not known for certain whether individuals infected with SARS–CoV-2 who subsequently recover will be protected, either fully or partially, from future infection with SARS–CoV-2 or how long protective immunity may last.